Treatment of Erdheim-Chester disease with cladribine: A rational approach [14]

British Journal of Ophthalmology

Volumn 88, Issue 6, 2004, Pages 844-847

  Myra, C ^a,d   Sloper, L ^a,d   Tighe, P J ^a   McIntosh, R S ^a   Stevens, S E ^a   Gregson, R H S ^b   Sokal, M ^c   Haynes, A P ^c   Powell, R J ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^d NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE; CYCLOSPORIN; ETOPOSIDE;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DISEASE COURSE; ERDHEIM CHESTER DISEASE; EYE BIOPSY; HUMAN; HYPERTENSION; LETTER; MALE; MEDICAL EXAMINATION; NEPHROTOXICITY; PRIORITY JOURNAL;

CLADRIBINE; CYTOKINES; ERDHEIM-CHESTER DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED;

EID: 2642553950     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2003.035584     Document Type: Letter

References (14)

1. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, et al. Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine 1996;75:157-69.
2. Alper MG, Zimmerman LE, Piana FG. Orbital manifestations of Erdheim-Chester disease. Trans Am Ophthalmol Soc 1983;81:64-85.
3. Wright RA, Hermann RC, Parisi JE. Neurological manifestations of Erdheim-Chester disease. J Neurol Neurosurg Psychiatry 1999;66:72-5.
4. Miller RL, Sheeler LR, Bauer TW, et al. Erdheim-Chester disease. Case report and review of the literature. Am J Med 1986;80:1230-6.
5. Rozenberg I, Wechsler J, Koenig F, et al. Erdheim-Chester disease presenting as malignant exophthalmos. Br J Radiol 1986;59:173-7.
6. Esmaeli B, Ahmadi A, Tang R, et al. Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease. Am J Ophthalmol 2001;132:945-7.
7. Sandrock D, Merino MJ, Scheffknecht BH, et al. Scintigraphic findings and follow up in Erdheim-Chester disease. Eur J Nucl Med 1990;16:55-60.
8. Babu RP, Lansen TA, Chadburn A, et al. Erdheim-Chester disease of the central nervous system. Report of two cases. J Neurosurg 1997;86:888-92.
9. Carrera CJ, Terai C, Lotz M, et al. Potent toxicity of 2-chlorodeoxyadenosine towards human monocytes in vitro and in vivo: a novel approach to immunosuppressive therapy. J Clin Invest 1990;86:1480.
10. Seto S, Carrera CJ, Kubota M, et al. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes. J Clin Invest 1985;75:377.
11. Juliusson G, Lenkei R, Liliemark J. Flow cytometry of blood and bone marrow cells from patients with hairy cell leukoemio: phenotype of hoiry cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine. Blood 1994;83:3672.
12. Saven A, Burian C. Cladribine activity in adult Langerhans-cell histiocytosis. Blood 1999;93:4125-30.
13. Sheidow TG, Nicolle DA, Heathcote JG. Erdheim-Chester disease: two cases of orbital involvement. Eye 2000;14:606-12.
14. Kobayashi K, Vogelzang NJ, O'Brien SM, et al. A phase 1 study of intermittent infusion of cladribine in patients with solid tumours. Cancer 1994;74:168-73.